Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy.

Yuichiro Kikawa,Yasuhiro Hagiwara,Tomomi Fujisawa,Kazuhiro Araki,Takayuki Iwamoto,Takafumi Sangai,Tadahiko Shien,Shintaro Takao,Reiki Nishimura,Masato Takahashi,Tatsuya Toyama,Tomohiko Aihara,Hirofumi Mukai,Naruto Taira

PloS one（2022）

引用 0|浏览18

暂无评分

摘要

Maintaining the HRQOL as determined by FACT-ES may be associated with clinical benefits in patients with acquired endocrine-resistant MBC treated with ET.

查看译文

关键词

breast cancer,therapy-endocrine therapy-endocrine,health-related

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要